3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
8
Plasma cell
3
Gynecologic
3
Head & Neck
2
Other hematologic neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
19
Carcinoma, Hepatocellular
18
Pancreatic Neoplasms
14
Colorectal Neoplasms
11
Esophageal Neoplasms
8
Neoplasm Metastasis
7
Biliary Tract Neoplasms
7
Liver Neoplasms
6
Cholangiocarcinoma
6
Breast Neoplasms
6
Neoplasms
5
Lung Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Melanoma
3
Sarcoma
2
Rectal Neoplasms
2
Advanced Pancreatic Cancer
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Squamous Cell Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Oligometastatic Gastrointestinal Cancer
1
Interventions
Oxaliplatin
10
Gemcitabine
8
Cisplatin
7
Hepatectomy
6
Fluorouracil
6
Radiofrequency Ablation
5
Liver Transplantation
5
Irinotecan
5
Capecitabine
5
lenvatinib
4
Paclitaxel
4
Neoadjuvant Therapy
4
Folfox protocol
4
Cetuximab
4
Aspirin
4
tislelizumab
3
Surgical Procedures, Operative
3
Nivolumab
3
Carboplatin
3
titanium silicide
2
durvalumab
2
apatinib
2
Trastuzumab
2
S 1 (combination)
2
Leucovorin
2
Lamivudine
2
Introns
2
Ethiodized Oil
2
Drug Therapy
2
DNA, Mitochondrial
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Injections
×
Gastrointestinal
×
Clear all
NCT05250791
2023-06-09
FLICOR
Imperial College London
Phase NA
Unknown
50 enrolled